The concentrative nucleoside transporter 2 (CNT2) mediates the uptake of both natural nucleosides and nucleoside-derived drugs. Therefore, it is important both physiologically and pharmacologically. However, CNT2 expression is significantly repressed in colorectal cancer (CRC). Here, we have elucidated the mechanism(s) underlying CNT2 repression in CRC.
Pubmed ID: 30076612 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This polyclonal targets Histone H3 (tri methyl K4)
View all literature mentionsThis unknown targets normal rabbit IgG
View all literature mentionsThis polyclonal targets SLC28A2 antibody
View all literature mentionsThis monoclonal targets Human Histone H3
View all literature mentionsThis polyclonal targets H3K27ac
View all literature mentionsThis polyclonal targets acetyl-Histone H4
View all literature mentionsThis polyclonal targets Histone H3 (acetyl K18) antibody - ChIP Grade
View all literature mentionsThis polyclonal targets Histone H3, trimethyl (Lys27)
View all literature mentionsThis polyclonal targets HIST1H3A
View all literature mentionsThis monoclonal targets
View all literature mentionsThis monoclonal targets Human Histone H3
View all literature mentions